Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tenon Medical, Inc. ( (TNON) ) has issued an announcement.
On August 1, 2025, Tenon Medical, Inc. acquired sacroiliac joint-specific assets from SiVantage, expanding its portfolio with SImmetry and SImmetry+ technologies. This acquisition enhances Tenon’s capabilities in sacroiliac joint fusion, providing a multi-product, multi-approach solution backed by clinical data. The transaction is expected to contribute to immediate revenue growth and strengthens Tenon’s market position by integrating SiVantage’s technologies and leadership into its operations. The acquisition also includes employment agreements with SiVantage’s co-founders, further bolstering Tenon’s commercial leadership. Additionally, Tenon acquired assets from SIMPL Medical, LLC, focusing on posterior sacroiliac implant technology, with a royalty-based purchase structure contingent on future performance milestones.
The most recent analyst rating on (TNON) stock is a Buy with a $32.00 price target. To see the full list of analyst forecasts on Tenon Medical, Inc. stock, see the TNON Stock Forecast page.
Spark’s Take on TNON Stock
According to Spark, TipRanks’ AI Analyst, TNON is a Neutral.
Tenon Medical, Inc. shows strong growth potential due to FDA clearances and a solid intellectual property portfolio, which are supported by a significant cash infusion. However, profitability challenges, negative valuation metrics, and mixed technical signals weigh down the overall score. The company’s reliance on external financing and flat revenue growth are key risks.
To see Spark’s full report on TNON stock, click here.
More about Tenon Medical, Inc.
Tenon Medical, Inc. is a medical technology company formed in 2012, specializing in the development of innovative solutions for sacroiliac joint (SIJ) disorders. The company offers the Catamaran SI Joint Fusion System, a less invasive approach to SI joint fusion using a robust titanium implant. Tenon focuses on primary SI joint procedures, revision procedures of failed implants, and augmenting spinal fusion.
Average Trading Volume: 4,411,641
Technical Sentiment Signal: Sell
Current Market Cap: $10.63M
For detailed information about TNON stock, go to TipRanks’ Stock Analysis page.